(IAC) IAC - Overview
Sector: Communication Services | Industry: Internet Content & Information | Exchange: NASDAQ (USA) | Market Cap: 3.293m USD | Total Return: 23.6% in 12m
Avg Turnover: 47.7M
Qual. Beats: 0
Rev. Trend: -97.5%
Qual. Beats: 0
Warnings
Earnings expected to drop: P/E 27.2 → Forward 200.0
Altman Z'' 0.67 < 1.0 - financial distress zone
Extended 1w
Tailwinds
Idiosyncratic Leader
IAC Inc. is an American media and internet holding company that manages a diverse portfolio of digital assets and publishing brands. The company operates through several distinct segments, including Dotdash Meredith, which controls prominent lifestyle and informational publications such as People, Investopedia, and Better Homes & Gardens. Its business model relies heavily on advertising revenue, affiliate marketing, and subscription services across its digital and print platforms.
Beyond traditional media, IAC maintains a significant footprint in specialized service marketplaces and search tools. The company owns Care.com, a platform connecting families with caregivers, and Vivian Health, a recruitment marketplace for healthcare professionals. This conglomerate structure allows IAC to leverage centralized capital allocation while operating in the Interactive Media & Services sector, where scale and audience data are primary competitive advantages.
Investors looking for deeper fundamental analysis can find additional metrics on ValueRay.
- Dotdash Meredith digital advertising revenue growth and print magazine transition efficiency
- Angi Inc. equity stake valuation and turnaround progress impacting consolidated balance sheet
- Care.com membership growth and corporate caregiver benefit adoption rates
- Search segment traffic acquisition costs and Google algorithm dependency risks
- Strategic portfolio optimization through acquisitions and divestitures of digital media assets
| Net Income: 116.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.72 > 1.0 |
| NWC/Revenue: 50.36% < 20% (prev 37.60%; Δ 12.76% < -1%) |
| CFO/TA 0.01 > 3% & CFO 82.1m > Net Income 116.5m |
| Net Debt (307.8m) to EBITDA (400.4m): 0.77 < 3 |
| Current Ratio: 3.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.6m) vs 12m ago -5.64% < -2% |
| Gross Margin: 64.57% > 18% (prev 0.66%; Δ 6.39k% > 0.5%) |
| Asset Turnover: 32.06% > 50% (prev 39.46%; Δ -7.40% > 0%) |
| Interest Coverage Ratio: 2.37 > 6 (EBITDA TTM 400.4m / Interest Expense TTM 117.6m) |
| A: 0.17 (Total Current Assets 1.55b - Total Current Liabilities 419.8m) / Total Assets 6.82b |
| B: -0.10 (Retained Earnings -714.9m / Total Assets 6.82b) |
| C: 0.04 (EBIT TTM 278.9m / Avg Total Assets 7.00b) |
| D: -0.33 (Book Value of Equity -728.9m / Total Liabilities 2.23b) |
| Altman-Z'' = 0.67 = B |
| DSRI: 1.06 (Receivables 328.8m/391.8m, Revenue 2.25b/2.84b) |
| GMI: 1.02 (GM 64.57% / 66.00%) |
| AQI: 1.01 (AQ_t 0.73 / AQ_t-1 0.72) |
| SGI: 0.79 (Revenue 2.25b / 2.84b) |
| TATA: 0.01 (NI 116.5m - CFO 82.1m) / TA 6.82b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 44.89 with a total of 943,833 shares traded.
Over the past week, the price has changed by +9.04%,
over one month by +0.70%,
over three months by +17.15% and
over the past year by +23.63%.
IAC has received a consensus analysts rating of 4.29. Therefore, it is recommended to buy IAC.
- StrongBuy: 7
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 52.2 | 16.2% |
P/E Trailing = 27.1595
P/E Forward = 200.0
P/S = 1.4106
P/B = 0.723
P/EG = 12.9069
Revenue TTM = 2.25b USD
EBIT TTM = 278.9m USD
EBITDA TTM = 400.4m USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 24.5m USD (from shortTermDebt, last quarter)
Debt = 1.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 307.8m USD (calculated: Debt 1.42b - CCE 1.11b)
Enterprise Value = 3.60b USD (3.29b + Debt 1.42b - CCE 1.11b)
Interest Coverage Ratio = 2.37 (Ebit TTM 278.9m / Interest Expense TTM 117.6m)
EV/FCF = 60.40x (Enterprise Value 3.60b / FCF TTM 59.6m)
FCF Yield = 1.66% (FCF TTM 59.6m / Enterprise Value 3.60b)
FCF Margin = 2.65% (FCF TTM 59.6m / Revenue TTM 2.25b)
Net Margin = 5.19% (Net Income TTM 116.5m / Revenue TTM 2.25b)
Gross Margin = 64.57% ((Revenue TTM 2.25b - Cost of Revenue TTM 795.5m) / Revenue TTM)
Gross Margin QoQ = 62.22% (prev 64.97%)
Tobins Q-Ratio = 0.53 (Enterprise Value 3.60b / Total Assets 6.82b)
Interest Expense / Debt = 8.28% (Interest Expense 117.6m / Debt 1.42b)
Taxrate = 21.0% (US default 21%)
NOPAT = 220.3m (EBIT 278.9m * (1 - 21.00%))
Current Ratio = 3.69 (Total Current Assets 1.55b / Total Current Liabilities 419.8m)
Debt / Equity = 0.31 (Debt 1.42b / totalStockholderEquity, last quarter 4.55b)
Debt / EBITDA = 0.77 (Net Debt 307.8m / EBITDA 400.4m)
Debt / FCF = 5.16 (Net Debt 307.8m / FCF TTM 59.6m)
Total Stockholder Equity = 4.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.66% (Net Income 116.5m / Total Assets 6.82b)
RoE = 2.13% (Net Income TTM 116.5m / Total Stockholder Equity 5.46b)
RoCE = 4.07% (EBIT 278.9m / Capital Employed (Equity 5.46b + L.T.Debt 1.40b))
RoIC = 3.43% (NOPAT 220.3m / Invested Capital 6.42b)
WACC = 8.53% (E(3.29b)/V(4.71b) * Re(9.39%) + D(1.42b)/V(4.71b) * Rd(8.28%) * (1-Tc(0.21)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -80.90 | Cagr: -5.73%
[DCF] Terminal Value 72.42% ; FCFF base≈139.0m ; Y1≈121.9m ; Y5≈98.5m
[DCF] Fair Price = 17.89 (EV 1.53b - Net Debt 307.8m = Equity 1.23b / Shares 68.6m; r=8.53% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.37 | # QB: 0
Revenue Correlation: -97.48 | Revenue CAGR: -23.93% | SUE: -0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.17 | Chg30d=+19.41% | Revisions=-20% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.25 | Chg30d=+4.06% | Revisions=-20% | Analysts=5
EPS current Year (2026-12-31): EPS=1.27 | Chg30d=-28.27% | Revisions=-20% | GrowthEPS=+392.4% | GrowthRev=-23.1%
EPS next Year (2027-12-31): EPS=2.57 | Chg30d=+13.54% | Revisions=+0% | GrowthEPS=+101.5% | GrowthRev=+0.5%
[Analyst] Revisions Ratio: -20%